Form 4: BioLife Solutions CEO Roderick de Greef Reports Acquisition of 112,835 Shares of Common Stock

Roderick de Greef, President and CEO of BioLife Solutions, reports acquiring 112,835 shares of common stock on March 18, 2025, according to a Form 4 filing with the SEC.

Summary

• On March 18, 2025, Roderick de Greef, the President and CEO of BioLife Solutions Inc., acquired 112,835 shares of common stock.
• Following the transaction, de Greef directly owns 527,793 shares of BioLife Solutions common stock.
• The acquisition was reported on a Form 4 filing with the Securities and Exchange Commission.
• The restricted stock was granted under the BioLife Solutions 2023 Omnibus Performance Incentive Plan as part of 2025 compensation.
• The restricted stock vests 25% on the first anniversary of the grant date, and then quarterly in 12 equal installments.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the CEO's stock acquisition suggests confidence in the company's future. However, it's a routine filing and doesn't provide groundbreaking information.

Positives

• The CEO's acquisition of shares may signal confidence in the company's future performance.
• The vesting schedule of the restricted stock aligns the CEO's interests with the long-term performance of the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock suggests a multi-year commitment from the CEO.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's prospects. This acquisition by the CEO could be interpreted as a positive signal.

Stakeholder Impact

• Shareholders may view the CEO's stock acquisition as a positive sign.
• The vesting schedule of the restricted stock aligns the CEO's interests with those of the shareholders.

Key Dates

Keywords

BioLife Solutions, BLFS, Roderick de Greef, SEC Form 4, Insider Trading, Stock Acquisition, Common Stock, Beneficial Ownership, 2023 Omnibus Performance Incentive Plan, Restricted Stock